CMO and CDMO biotechnology Market
CMO and CDMO biotechnology Market Scope: Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
CMO and CDMO biotechnology Market Size and Growth
The CMO and CDMO biotechnology market is experiencing robust growth, driven by increasing demand for outsourced manufacturing services. The market is projected to reach approximately $13 billion by 2025, reflecting a compound annual growth rate (CAGR) of 8%. Favorable regulatory conditions and technological advancements are enhancing market dynamics and opportunities. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Patheon
◍ Catalent
◍ Samsung Biologics
◍ Lonza.
◍ Boehringer Ingelheim
◍ Samsung BioLogics
◍ AGC Biologics
◍ WuXi Biologics
◍ AbbVie
◍ Avid Bioservices
◍ Fujifilm Diosynth Biotechnologies
◍ KBI Biopharma (JSR Corporation)
◍ Cytovance Biologics
◍ Xpress Biologic
◍ Rentschler Biopharma
The CMO and CDMO biotechnology market features key players like Patheon, Catalent, and Lonza, providing contract manufacturing and development services for biopharmaceuticals. Companies enhance growth through expertise in biologics, scalability, and innovation.
Notable revenues include:
- Patheon: $1.6 billion
- Lonza: $5.4 billion
- Catalent: $4.4 billion.
Request Sample Report
Market Segmentation
By Application
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
